These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 12596604

  • 21. Assessment for chronic kidney disease service in high-risk patients at community health clinics.
    Patel HR, Pruchnicki MC, Hall LE.
    Ann Pharmacother; 2005 Jan; 39(1):22-7. PubMed ID: 15546945
    [Abstract] [Full Text] [Related]

  • 22. Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    McFarlane SI, Chen SC, Whaley-Connell AT, Sowers JR, Vassalotti JA, Salifu MO, Li S, Wang C, Bakris G, McCullough PA, Collins AJ, Norris KC, Kidney Early Evaluation Program Investigators.
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S46-55. PubMed ID: 18359408
    [Abstract] [Full Text] [Related]

  • 23. Anemia and heart failure in chronic kidney disease.
    Locatelli F, Pozzoni P, Del Vecchio L.
    Semin Nephrol; 2005 Nov; 25(6):392-6. PubMed ID: 16298261
    [Abstract] [Full Text] [Related]

  • 24. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Nov; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 25. Assessing hyporesponse to Epoetin alfa: an algorithm approach: case study of the anemic patient.
    Wingard R.
    Nephrol Nurs J; 2000 Oct; 27(5):517-20. PubMed ID: 16649327
    [Abstract] [Full Text] [Related]

  • 26. Creating a better environment to treat anemia in patients with CKD.
    Sinnen MT.
    Nephrol Nurs J; 2007 Oct; 34(6):645-9. PubMed ID: 18203573
    [No Abstract] [Full Text] [Related]

  • 27. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
    Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, Foley RN, Chen SC, Arneson TJ.
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S71-7. PubMed ID: 19231764
    [Abstract] [Full Text] [Related]

  • 28. A review of anemia management in the oncology setting: a focus on implementing standing orders.
    Mickle J, Reinke D.
    Clin J Oncol Nurs; 2007 Aug; 11(4):534-9. PubMed ID: 17723966
    [Abstract] [Full Text] [Related]

  • 29. [Methoxy polyethylene glycol epoetin beta].
    Taéron C.
    Rev Infirm; 2010 Apr; (159):47-9. PubMed ID: 20432857
    [No Abstract] [Full Text] [Related]

  • 30. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [Abstract] [Full Text] [Related]

  • 31. Cancer-related anemia: clinical review and management update.
    Hurter B, Bush NJ.
    Clin J Oncol Nurs; 2007 Jun; 11(3):349-59. PubMed ID: 17623620
    [Abstract] [Full Text] [Related]

  • 32. The self-management experience of people with mild to moderate chronic kidney disease.
    Costantini L, Beanlands H, McCay E, Cattran D, Hladunewich M, Francis D.
    Nephrol Nurs J; 2008 Jun; 35(2):147-55; quiz 156. PubMed ID: 18472683
    [Abstract] [Full Text] [Related]

  • 33. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R, Kalantar-Zadeh K.
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
    Kalaitzidis R, Li S, Wang C, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S22-31. PubMed ID: 19285608
    [Abstract] [Full Text] [Related]

  • 36. Glomerulonephritis and managing the risks of chronic renal disease.
    Singh GR.
    Pediatr Clin North Am; 2009 Dec; 56(6):1363-82. PubMed ID: 19962026
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
    Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F, Anemia Correction in Diabetes Study Investigators.
    Am J Kidney Dis; 2007 Feb; 49(2):194-207. PubMed ID: 17261422
    [Abstract] [Full Text] [Related]

  • 39. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 40. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
    Palmer BF.
    Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.